396 filings
424B4
BIOCQ
Biocept Inc
11 Dec 19
Prospectus supplement with pricing info
12:00am
8-K
BIOCQ
Biocept Inc
11 Dec 19
Biocept Announces Pricing of $10.0 Million Underwritten Public Offering
12:00am
EFFECT
BIOCQ
Biocept Inc
10 Dec 19
Notice of effectiveness
12:15am
S-1/A
BIOCQ
Biocept Inc
IPO registration (amended)
5 Dec 19
9:46pm
S-1/A
BIOCQ
Biocept Inc
IPO registration (amended)
4 Dec 19
9:11pm
CORRESP
afoc0
4 Dec 19
Correspondence with SEC
12:00am
CORRESP
nzajws4w868d8ujr
4 Dec 19
Correspondence with SEC
12:00am
8-K
i15ei8vq26ay2
13 Nov 19
Biocept Reports Third Quarter 2019 Financial Results
4:15pm
UPLOAD
7xhrmx3ye5wu3 qe0y
5 Nov 19
Letter from SEC
12:00am
8-K
zppbozw7eqarc 0s
27 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
S-8
04on2pft
15 Aug 19
Registration of securities for employees
12:00am
8-K
x9hr nocipug
12 Aug 19
Biocept Reports Second Quarter 2019 Financial Results
4:20pm
8-K
p9km2z2v
18 Jul 19
Entry into a Material Definitive Agreement
6:04am
8-K
losofrpg5t1il633b
19 Jun 19
Departure of Directors or Certain Officers
5:17pm
4
pdm5kgov6cro iv
19 Jun 19
BIOCEPT / Michael W. Nall ownership change
4:24pm